Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4001
Eledon Pharmaceuticals
ELDN
$202M
| $276K | ﹤0.01% |
101,878
+31,878
| +46% | +$95.6K |
2024 Q4
2 quarters
|
|
|
OPOF
4002
DELISTED
Old Point Financial
OPOF
| $276K | ﹤0.01% |
+7,030
| New | +$272K |
2025 Q2
0 quarters
|
|
4003
First National Corp
FXNC
$272M
| $275K | ﹤0.01% |
14,142
+14,067
| +18,756% | +$278K |
2024 Q4
2 quarters
|
|
4004
BCB Bancorp
BCBP
$261M
| $275K | ﹤0.01% |
32,686
+8,719
| +36% | +$73.9K |
2022 Q2
12 quarters
|
|
|
PVLA
4005
Palvella Therapeutics
PVLA
$1.91B
| $275K | ﹤0.01% |
12,179
+12,116
| +19,232% | +$284K |
2017 Q2
32 quarters
|
|
4006
Vanguard Real Estate ETF
VNQ
$35.4B
| $274K | ﹤0.01% |
3,077
+2,102
| +216% | +$185K |
2022 Q2
12 quarters
|
|
4007
Johnson Outdoors
JOUT
$471M
| $274K | ﹤0.01% |
9,052
+4,263
| +89% | +$111K |
2020 Q2
20 quarters
|
|
4008
PUT
Liquidia Corp
LQDA
$2.56B
| $273K | ﹤0.01% |
+21,900
| New | +$324K |
2025 Q2
0 quarters
|
|
4009
MediWound
MDWD
$175M
| $272K | ﹤0.01% |
14,053
+3,926
| +39% | +$74K |
2024 Q2
4 quarters
|
|
|
SLDE
4010
Slide Insurance Holdings
SLDE
$2.76B
| $271K | ﹤0.01% |
+12,500
| New | +$269K |
2025 Q2
0 quarters
|
|
4011
OP Bancorp
OPBK
$231M
| $271K | ﹤0.01% |
20,838
+15,382
| +282% | +$188K |
2024 Q3
3 quarters
|
|
4012
Blackstone Secured Lending
BXSL
$5.5B
| $271K | ﹤0.01% |
8,800
| – | – |
2024 Q4
2 quarters
|
|
4013
First Capital
FCAP
$210M
| $270K | ﹤0.01% |
6,550
+6,332
| +2,905% | +$284K |
2019 Q2
24 quarters
|
|
|
ALMS
4014
Alumis Inc
ALMS
$887M
| $270K | ﹤0.01% |
90,060
+63,616
| +241% | +$300K |
2024 Q3
3 quarters
|
|
4015
iShares Expanded Tech Sector ETF
IGM
$11.6B
| $270K | ﹤0.01% |
2,400
| – | – |
2024 Q4
2 quarters
|
|
|
ZBIO
4016
Zenas BioPharma
ZBIO
$1.84B
| $270K | ﹤0.01% |
27,813
+11,653
| +72% | +$113K |
2024 Q3
3 quarters
|
|
4017
Neurogene
NGNE
$513M
| $269K | ﹤0.01% |
18,011
+3,782
| +27% | +$59.3K |
2024 Q1
5 quarters
|
|
4018
Citizens Community Bancorp
CZWI
$206M
| $268K | ﹤0.01% |
19,445
+17,573
| +939% | +$250K |
2024 Q3
3 quarters
|
|
|
CAI
4019
Caris Life Sciences
CAI
$8B
| $267K | ﹤0.01% |
+10,000
| New | +$270K |
2025 Q2
0 quarters
|
|
|
EXK
4020
Endeavour Silver
EXK
$2.55B
| $267K | ﹤0.01% |
54,167
-527
| -1% | -$2.08K |
2024 Q2
4 quarters
|
|
4021
Townsquare Media
TSQ
$83M
| $266K | ﹤0.01% |
33,675
-14,399
| -30% | -$102K |
2020 Q2
20 quarters
|
|
4022
Core Molding Technologies
CMT
$204M
| $266K | ﹤0.01% |
16,036
+6,613
| +70% | +$104K |
2023 Q1
9 quarters
|
|
4023
Frequency Electronics
FEIM
$970M
| $264K | ﹤0.01% |
11,646
+11,564
| +14,102% | +$214K |
2024 Q3
3 quarters
|
|
4024
Lifezone Metals
LZM
$346M
| $264K | ﹤0.01% |
64,015
+27,227
| +74% | +$101K |
2024 Q2
4 quarters
|
|
4025
Atomera
ATOM
$184M
| $264K | ﹤0.01% |
52,312
+30,876
| +144% | +$165K |
2024 Q4
2 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.